| Value | ₹25.00 Cr |
|---|
BSE filing, NSE: DDIL. Summary written from the filing by ALFA Finder's alert engine.
Deep Health AI India Ltd: key numbers
- Share price
- ₹1.60
- Market cap
- ₹23.06 Cr
- Revenue (annual)
- ₹4.25 Cr
- Net profit (annual)
- ₹1.13 Cr
- P/E (TTM)
- -21.4×Sector 49.8×
- Promoter holding
- 0.03%+0.00% QoQ
- FII holding
- 0.35%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Deep Health AI India Ltd
All →Deep Health AI India Board Meeting Date
Deep Health AI will hold a board meeting on 3 November 2026 for unaudited quarterly and half-year results. Trading window stays closed until 48 hours after results.
Deep Health AI India Other Announcement
Deep Health AI India Ltd filed its quarterly shareholding pattern for the quarter ended September 30, 2026, as per regulatory requirements.
Deep Health AI India Acquisition Worth ₹10.35 Cr
Deep Health AI India Limited acquired debt and underlying security from Kshitij Polyline Limited for ₹10.35 Crore. The assignment secures rights in Sparion Infrastructure Private Limited.
- Value
- ₹10.35 Cr
Deep Health AI India Management Change
Deep Health AI India Limited appointed Virendra Choubisa as Non-Executive Director and M/s Vimal C Surana as statutory auditor, replacing outgoing auditor M/s VRSK & Co. LLP.
Deep Health AI India Annual General Meeting
Deep Health AI India Limited successfully concluded its 32nd Annual General Meeting on September 30, 2026, where all proposed resolutions were passed by the members.
Deep Health AI India Management Change
Deep Health AI India Limited has announced the resignation of Mr. Rajesh Nandkishore Pherwani as a Non-Executive Independent Director, effective September 11, 2026.
Other fund raise announcements
All →Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.
Gujarat Inject (Kerala) Fund Raise of ₹3 Cr
Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.
- Value
- ₹3.00 Cr
MosChip Technologies Fund Raise of ₹112.2 Cr
MosChip Technologies approved a preferential issue of 50,50,686 equity shares at Rs.222 to 69 investors, raising about Rs.112.19 Crore. The board approval covers the fund raise, with an AGM/postal ballot dated 25 November 2026.
- Value
- ₹112.2 Cr